IP Library Granted Patent US 8,349,553
Granted Patent B2
US 8,349,553 · App. 12/531,204 · Granted Jan 8, 2013

Jasmonate based assays for identifying compounds that selectively inhibit mitochondrial bound hexokinases

Assignees: Ramot at Tel Aviv University Ltd.; Sepal Pharma S.A.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,349,553
App. No.
12/531,204
Granted
Jan 8, 2013
Kind
B2
Abstract

The present invention provides compositions comprising compounds that selectively bind to hexokinases thereby promoting dissociation of these enzymes from mitochondria, and methods of use of such compounds and compositions to induce cell death in diseases and disorders characterized by the high levels of mitochondrial bound hexokinase. The present invention further discloses methods and assays for detecting and identifying molecules having these activities.

Claims (11)

1. An assay for identifying a chemical compound having a potential anti-tumor effect comprising comparing the activities of the compound and a jasmonate derivative known to have anti-tumor activity in at least one of the following: dissociating hexokinase from mitochondria, interfering with hexokinase binding to a voltage dependent anion channel, and binding to hexokinase directly; and selecting a compound having an equal or greater anti-tumor activity as compared with at least one anti-tumor activity of said jasmonate derivative selected from the group consisting of: dissociating hexokinase from mitochondria, interfering with hexokinase binding to a voltage dependent anion channel, and binding to hexokinase directly, thereby identifying a chemical compound having a potential anti-tumor effect.

2. The assay according to claim 1 , wherein the jasmonate derivative is methyl jasmonate.

3. The assay according to claim 1 , wherein the chemical compound is a jasmonate derivative other than methyl jasmonate.

4. An assay for identifying a chemical compound having a potential anti-tumor effect comprising: introducing the compound into a cell free system comprising mitochondria; measuring the ability of said compound to induce dissociation of a hexokinase from the mitochondria; comparing the dissociation of hexokinase in the presence of said compound to the dissociation achieved by a jasmonate derivative known to have anti-tumor activity; and selecting a compound having an equal or greater dissociation as compared with said jasmonate derivative, thereby identifying a chemical compound having a potential anti-tumor effect.

5. The assay according to claim 4 , wherein the compound selectively induces tumor cell death.

6. The assay according to claim 4 , wherein the jasmonate derivative is methyl jasmonate.

7. The assay according to claim 4 , wherein the chemical compound is a jasmonate derivative other than methyl jasmonate.

8. An assay for identifying a chemical compound having a potential anti-tumor effect comprising: measuring the direct binding of the compound to at least one hexokinase subtype; comparing this binding to the binding achieved by a jasmonate derivative known to have anti-tumor activity, and selecting a chemical compound having an equal or greater binding as compared with said jasmonate derivative, thereby identifying a chemical compound having a potential anti-tumor effect.

9. The assay according to claim 8 , wherein the compound selectively induces tumor cell death.

10. The assay according to claim 8 , wherein the jasmonate derivative is methyl jasmonate.

11. The assay according to claim 8 , wherein the chemical compound is a jasmonate derivative other than methyl jasmonate.

Assignments (4)
LICENSE Recorded Jun 8, 2014
From: RAMOT AT TEL AVIV UNIVERSITY LTD.
To: VIDAC PHARMA LTD.
Reel/Frame 033052/0829 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 5, 2014
From: SEPAL PHARMA S.A.
To: RAMOT AT TEL AVIV UNIVERSITY LTD.
Reel/Frame 033042/0756 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 23, 2009
From: FLESCHER, ELIEZER; GOLDIN, NATALIA
To: RAMOT AT TEL AVIV UNIVERSITY LTD.
Reel/Frame 023555/0792 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 23, 2009
From: HERZBERG, MAX
To: SEPAL PHARMA S.A.
Reel/Frame 023555/0834 →
Continuity (2)
Provisional Application 60918032 · Mar 15, 2007
Related Publication 20100087384A1 · Apr 8, 2010